JPH07503474A - 3−セフェム−4−カルボン酸誘導体の精製方法 - Google Patents
3−セフェム−4−カルボン酸誘導体の精製方法Info
- Publication number
- JPH07503474A JPH07503474A JP5513698A JP51369893A JPH07503474A JP H07503474 A JPH07503474 A JP H07503474A JP 5513698 A JP5513698 A JP 5513698A JP 51369893 A JP51369893 A JP 51369893A JP H07503474 A JPH07503474 A JP H07503474A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- amino
- cephem
- compound
- propen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.7−アミノ−3−[(Z)−1−プロペン−1−イル]−3−セフェム−4 −カルボン酸及び7−アミノ−3−[(E)−1−プロペン−1−イル]−3− セフェム−4−カルボン酸の混合物中の7−アミノ−3−[(E)−1−プロペ ン−1−イル]−3−セフェム−4−カルボン酸を枯渇させる方法であって、 a)式I′ ▲数式、化学式、表等があります▼I′(式中、プロペニル基はZ及びE配置を 有する)の化合物の塩酸塩を、式I ▲数式、化学式、表等があります▼I (式中、プロペニル基はZ及びE配置を有する)の化合物及び塩酸から式I′の Z及びE異性体が異なる溶解度を有する溶剤又は溶剤混合物中で形成すること、 又は、Z及びE異性体が異なる溶解度を有する溶剤又は溶剤混合物中に、式I′ の化合物のZ/E混合物中の7−アミノ−3−[(E)−1−プロペン−1−イ ル]−3−セフェム−4−カルボン酸の塩酸塩の少なくとも一部を溶解させ、式 I′の濃縮されたZ異性体を回収すること、及び任意で、pHを調整することに よって、得られた式I′の化合物をE量の少ない式1の遊離化合物に転化するこ と、あるいは b)式II ▲数式、化学式、表等があります▼II[式中、プロペニル基はZ及びE配置を 有し、X+はLi+、K+、Na+、アンモニウム又は式III▲数式、化学式 、表等があります▼III(式中、R1、R2及びR3は独立して水素、(C1 〜8)アルキル、任意に置換されたベンジル、(C4〜8)シクロアルキルであ るか、又は、R1とR2及び窒素原子は、任意で1又は2個の付加ヘテロ原子を 含む5又は6員の複素環を表し、R3が上記定義の通りであり、ここでR1,R 2もしくはR3の1つが水素でない) の陽イオンである]の塩を、 式IIのZ及びE異性体が異なる溶解度を有する溶剤又は溶剤混合物中で式Iの 化合物をリチウム、ナトリウムもしくはカリウム塩基又はアンモンニア又は式I V▲数式、化学式、表等があります▼IV(式中、R1、R2及びR3は上記定 義の通りである)のアミンと反応させ、得られた式IIの化合物を任意で補助溶 剤を添加することで沈殿させることによって、又はリチウム、ナトリウムもしく はカリウム塩基又はアンモンニアによって溶剤もしくは溶剤混合物中に式Iの化 合物を溶解させ、リチウム、ナトリウムもしくはカリウム源又は式IVのアミン 及び任意で補助溶剤を添加することで式IIの化合物を沈殿させることによって 形成し、及び 酸を添加して、式IIの化合物をE量の少ない式Iの化合物又は式I′のその塩 酸塩に転化すること、あるいはC)式Iの化合物の溶液を吸着クロマトグラフィ ーにかけることを含む、前記方法。 2,式I′の濃縮されたZ異性体を、任意に補助溶剤を添加することで生成物の 溶解度を調整することによって溶液から回収する請求項1a)に記載の方法。 3.結晶性の7−アミノ−3−[(Z)−1−プロペン−1−イル]−3−セフ ェム−4−カルボン酸塩酸塩。 4.Z/E比が91:9以下の7−アミノ−3−[(Z)−1−プロペン−1− イル]−3−セフェム−4−カルボン酸塩酸塩。 5.酢酸又は2−エチルヘキサン酸のリチウム、ナトリウムもしくはカリウム塩 のようなカルボン酸のリチウム、ナトリウムもしくはカリウム塩がLi+、Na +又はK+源として使用される請求項1b)に記載の方法。 6.Li+、Na+又はK+塩基として、その水酸化物、炭酸水素塩又は炭酸塩 が使用される請求項1b)に記載の方法。 7.活性炭、HP−20、HP−21、SP207、XAD1180、XAD1 6、XAD1600又はAmberchrome CG161を吸着剤として使 用する請求項1c)に記載の方法。 8.7−アミノ−3−[(Z)−1−プロペン−1−イル]−3−セフェム−4 −カルボン酸ジシクロヘキシルアンモニウム塩。 9.7−アミノ−3−[(Z)−1−プロペン−1−イル]−3−セフェム−4 −カルボン酸(2,4,4−トリメチルペンチル−2)アンモニウム塩。 10.式Iの化合物から請求項1に記載の方法によって製造されるセファノスポ リン。 11.7−アミノ−3−[(Z)−1−プロペン−1−イル]−3−セフェム− 4−カルボン酸及び7−アミノ−3−[(E)−1−プロベン−1−イル]−3 −セフェム−4−カルボン酸の混合物中の7−アミノ−3−[(E)−1−プロ ペン−1−イル]−3−セフェム−4−カルボン酸を枯渇させるための方法にお いて使用される式I′又はIIの化合物。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0019192A AT399876B (de) | 1992-02-05 | 1992-02-05 | Verfahren zur abreicherung von 7-amino-3-((e)-1- propen-1-yl)-3-cephem-4-carbonsäure |
AT191/92 | 1992-02-05 | ||
GB9225666.8 | 1992-12-09 | ||
GB929225666A GB9225666D0 (en) | 1992-12-09 | 1992-12-09 | Process for the depletion of 7-amino-3-((e)-propen-1-yl)-3-cephem-4-carboxylic acid |
GB191/92 | 1992-12-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07503474A true JPH07503474A (ja) | 1995-04-13 |
JP2825655B2 JP2825655B2 (ja) | 1998-11-18 |
Family
ID=25591794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5513698A Expired - Lifetime JP2825655B2 (ja) | 1992-02-05 | 1992-12-21 | 3−セフェム−4−カルボン酸誘導体の精製方法 |
Country Status (14)
Country | Link |
---|---|
US (3) | US5869648A (ja) |
EP (2) | EP0630380B1 (ja) |
JP (1) | JP2825655B2 (ja) |
KR (1) | KR950700311A (ja) |
AT (2) | ATE205214T1 (ja) |
CA (1) | CA2124322C (ja) |
DE (2) | DE69233249T2 (ja) |
DK (1) | DK0630380T3 (ja) |
ES (2) | ES2210047T3 (ja) |
GR (1) | GR3036985T3 (ja) |
PT (1) | PT630380E (ja) |
SG (1) | SG48415A1 (ja) |
TW (1) | TW230775B (ja) |
WO (1) | WO1993016084A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002510694A (ja) * | 1998-04-02 | 2002-04-09 | バイオケミ・ゲゼルシヤフト・エム・ベー・ハー | セファロスポリン誘導体の精製方法 |
WO2005118595A1 (ja) * | 2004-06-04 | 2005-12-15 | Otsuka Chemical Co., Ltd. | 3−アルケニルセフェム化合物の製造方法 |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE198892T1 (de) | 1993-11-17 | 2001-02-15 | Biochemie Gmbh | Trennung von cephalosporinisomeren |
US5648378A (en) * | 1995-06-07 | 1997-07-15 | Research Corporation Technologies, Inc. | 2-iminochromene derivatives as inhibitors of protein tyrosine kinase |
AT403049B (de) * | 1995-08-14 | 1997-10-27 | Biochemie Gmbh | Abreicherung von 7-adca in 3-vinyl-aca |
AT405283B (de) * | 1997-04-04 | 1999-06-25 | Biochemie Gmbh | Neues kristallines 7-(z)-(2-(2-aminothiazol-4-yl) -2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4- carbonsäure dicyclohexylammoniumsalz und verfahren zu dessen herstellung |
GB0118764D0 (en) * | 2001-08-01 | 2001-09-26 | Biochemie Gmbh | Organic compounds |
KR20050087776A (ko) * | 2002-08-13 | 2005-08-31 | 산도즈 아게 | 세프디니르 중간체 |
AU2003267733A1 (en) * | 2002-10-08 | 2004-05-04 | Ranbaxy Laboratories Limited | Process for the preparation of (z)-isomer enriched 7-amino-3-propen-1-yl-3-cephem-4- carboxylic acid |
US6903211B2 (en) * | 2002-10-30 | 2005-06-07 | Orchid Chemicals & Pharmaceuticals Limited | Process for the preparation of 3-propenyl cephalosporin DMF solvate |
CN100357294C (zh) * | 2003-03-24 | 2007-12-26 | 桑多斯股份公司 | 7-[2-(2-氨基噻唑-4-基)-2-羟基亚氨基乙酰胺-3-乙烯基-3-头孢烯-4-羧酸(顺式异构体)的新型晶体和其制备方法 |
WO2005100369A1 (en) * | 2004-04-13 | 2005-10-27 | Ranbaxy Laboratories Limited | Depletion of e-isomers in preparation of z-enriched 3-(2-substituted vinyl) cephalosporins |
GB2421024A (en) * | 2004-12-07 | 2006-06-14 | Sandoz Ag | Cefdinir crystalline form C |
US20070128268A1 (en) * | 2005-12-07 | 2007-06-07 | Herwig Jennewein | Pharmaceutical compositions comprising an antibiotic |
EP2367118A1 (en) | 2010-03-15 | 2011-09-21 | GMC Software AG | Method and devices for generating two-dimensional visual objects |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4107431A (en) * | 1970-01-23 | 1978-08-15 | Glaxo Laboratories Limited | Δ3 -3-Vinyl or substituted vinyl-4-carboxy cephalosporins |
US3769277A (en) * | 1970-01-23 | 1973-10-30 | Glaxo Lab Ltd | Preparation of delta3-4 carboxy cephalosporins having a 3-vinyl or substituted 3-vinyl group |
US4110534A (en) * | 1970-01-23 | 1978-08-29 | Glaxo Laboratories Limited | Process for the preparation of 3-vinyl and substituted vinyl cephalosporins |
US4065620A (en) * | 1971-06-14 | 1977-12-27 | Eli Lilly And Company | 3-(Substituted) vinyl cephalosporins |
US4520022A (en) * | 1983-01-28 | 1985-05-28 | Bristol-Myers Company | Substituted vinyl cephalosporins |
FR2580652B1 (fr) * | 1985-04-22 | 1989-01-06 | Bristol Myers Co | Acide 7-amino-3-propenylcephalosporanique et ses esters |
US4708955A (en) * | 1985-06-24 | 1987-11-24 | Bristol-Myers Company | 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof |
US4874856A (en) * | 1985-06-24 | 1989-10-17 | Bristol-Myers Company | 3-(substituted)propenyl-7-(aminothiazolylacetamido) ceph-3-em-4-carboxylic acids and esters thereof |
US4694079A (en) * | 1985-07-29 | 1987-09-15 | Bristol-Myers Company | 3-propenyl cephalosporin solvates |
US4727070A (en) * | 1985-11-25 | 1988-02-23 | Bristol-Myers Company | 3-Propenzl cephalosporin isomer separation process and derivative |
US4870168A (en) * | 1987-02-26 | 1989-09-26 | Bristol-Myers Company | 3-Unsaturated alkyl cephems from 3-triflyl cephems |
DE3734005A1 (de) * | 1987-05-26 | 1988-12-15 | Bayer Ag | Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
US4935508A (en) * | 1988-08-23 | 1990-06-19 | Bristol-Myers Company | Process for cephem prodrug esters |
DE3933934A1 (de) * | 1989-10-03 | 1991-04-11 | Bayer Ag | Verfahren zur herstellung von 7-amino-3-((z)-1-propen-1-yl)-3-cephem-4-carbonsaeure |
US5095012A (en) * | 1990-08-23 | 1992-03-10 | Bristol-Myers Squibb Company | Antibiotic c-7 catechol-substituted cephalosporin compounds, compositions, and method of use thereof |
DE69231815T2 (de) * | 1991-03-08 | 2001-09-27 | Biochemie Gmbh | Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren |
-
1992
- 1992-12-21 KR KR1019940702673A patent/KR950700311A/ko not_active IP Right Cessation
- 1992-12-21 DE DE69233249T patent/DE69233249T2/de not_active Expired - Fee Related
- 1992-12-21 EP EP93901714A patent/EP0630380B1/en not_active Expired - Lifetime
- 1992-12-21 JP JP5513698A patent/JP2825655B2/ja not_active Expired - Lifetime
- 1992-12-21 ES ES01104309T patent/ES2210047T3/es not_active Expired - Lifetime
- 1992-12-21 PT PT93901714T patent/PT630380E/pt unknown
- 1992-12-21 CA CA002124322A patent/CA2124322C/en not_active Expired - Fee Related
- 1992-12-21 AT AT93901714T patent/ATE205214T1/de not_active IP Right Cessation
- 1992-12-21 EP EP01104309A patent/EP1103555B1/en not_active Expired - Lifetime
- 1992-12-21 SG SG1996009496A patent/SG48415A1/en unknown
- 1992-12-21 DK DK93901714T patent/DK0630380T3/da not_active Application Discontinuation
- 1992-12-21 AT AT01104309T patent/ATE253583T1/de not_active IP Right Cessation
- 1992-12-21 ES ES93901714T patent/ES2162812T3/es not_active Expired - Lifetime
- 1992-12-21 DE DE69232048T patent/DE69232048T2/de not_active Expired - Fee Related
- 1992-12-21 WO PCT/EP1992/002965 patent/WO1993016084A1/en active IP Right Grant
- 1992-12-29 TW TW081110453A patent/TW230775B/zh not_active IP Right Cessation
-
1995
- 1995-06-06 US US08/466,306 patent/US5869648A/en not_active Expired - Fee Related
-
1998
- 1998-11-12 US US09/190,200 patent/US6136967A/en not_active Expired - Lifetime
-
2000
- 2000-05-04 US US09/564,833 patent/US6333409B1/en not_active Expired - Fee Related
-
2001
- 2001-10-23 GR GR20010401855T patent/GR3036985T3/el not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002510694A (ja) * | 1998-04-02 | 2002-04-09 | バイオケミ・ゲゼルシヤフト・エム・ベー・ハー | セファロスポリン誘導体の精製方法 |
WO2005118595A1 (ja) * | 2004-06-04 | 2005-12-15 | Otsuka Chemical Co., Ltd. | 3−アルケニルセフェム化合物の製造方法 |
Also Published As
Publication number | Publication date |
---|---|
KR950700311A (ko) | 1995-01-16 |
DE69233249T2 (de) | 2004-08-19 |
DE69232048T2 (de) | 2002-07-04 |
DE69232048D1 (de) | 2001-10-11 |
CA2124322A1 (en) | 1993-08-19 |
US6136967A (en) | 2000-10-24 |
ATE205214T1 (de) | 2001-09-15 |
EP1103555A1 (en) | 2001-05-30 |
ATE253583T1 (de) | 2003-11-15 |
US5869648A (en) | 1999-02-09 |
EP0630380A1 (en) | 1994-12-28 |
EP0630380B1 (en) | 2001-09-05 |
SG48415A1 (en) | 1998-04-17 |
EP1103555B1 (en) | 2003-11-05 |
DE69233249D1 (de) | 2003-12-11 |
PT630380E (pt) | 2002-02-28 |
JP2825655B2 (ja) | 1998-11-18 |
ES2162812T3 (es) | 2002-01-16 |
WO1993016084A1 (en) | 1993-08-19 |
ES2210047T3 (es) | 2004-07-01 |
DK0630380T3 (da) | 2001-12-10 |
TW230775B (ja) | 1994-09-21 |
CA2124322C (en) | 2007-04-17 |
US6333409B1 (en) | 2001-12-25 |
GR3036985T3 (en) | 2002-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07503474A (ja) | 3−セフェム−4−カルボン酸誘導体の精製方法 | |
NO157933B (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefemforbindelser. | |
JP3675863B2 (ja) | セファロスポリン異性体の分離 | |
JPH0564151B2 (ja) | ||
JP2655664B2 (ja) | 結晶性セファドロキシル一水塩の製造方法 | |
US5081116A (en) | Cephalosporin derivatives | |
EP0112164A2 (en) | Cephem compounds, and their production, and medicaments containing them | |
NO147916B (no) | Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser. | |
JP3547141B2 (ja) | 精製方法 | |
JPS6118786A (ja) | セフタジダイムの改良結晶化法 | |
JPS5953277B2 (ja) | 抗菌剤の製造方法 | |
US20060009639A1 (en) | Process for the preparation of cefpodoxime proxetil | |
GB2137998A (en) | Benzothienyl cephalosporin antibiotics | |
US3843642A (en) | Cephalosporin c derivatives | |
EP1029864B1 (en) | Process for the purification of a 3-cephem-4-carboxylic acid derivative | |
JP2959821B2 (ja) | チアゾリルアセトアミドセフェム誘導体 | |
KR100213444B1 (ko) | 세펨 유도체의 새로운 제조방법 | |
KR100443025B1 (ko) | 세팔로스포린이성체의분리방법 | |
JPH0613529B2 (ja) | 新規セフアロスポリン誘導体及び抗菌剤 | |
WO2005042543A1 (en) | Processes for the preparation of cephem derivatives | |
JPH085897B2 (ja) | 3−プロペニルセフェム誘導体 | |
JPS6366188A (ja) | 7−〔2−(2−アミノチアゾ−ル−4−イル)−3−ヒドロキシプロピオンアミド〕セフアロスポリン化合物およびその製造法 | |
JPH05331174A (ja) | 7−アシル−3−置換カルバモイルオキシセフェム化合物およびその製造法 | |
JPS6210513B2 (ja) | ||
JPH03128381A (ja) | チアゾリルアセトアミド―3―セフェム誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080911 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080911 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090911 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100911 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100911 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110911 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120911 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130911 Year of fee payment: 15 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130911 Year of fee payment: 15 |